389 related articles for article (PubMed ID: 23202314)
1. Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?
Knapp O; McArthur JR; Adams DJ
Toxins (Basel); 2012 Nov; 4(11):1236-60. PubMed ID: 23202314
[TBL] [Abstract][Full Text] [Related]
2. Venom Peptides From Cone Snails: Pharmacological Probes for Voltage-Gated Sodium Channels.
Green BR; Olivera BM
Curr Top Membr; 2016; 78():65-86. PubMed ID: 27586281
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.
Green BR; Bulaj G; Norton RS
Future Med Chem; 2014 Oct; 6(15):1677-98. PubMed ID: 25406007
[TBL] [Abstract][Full Text] [Related]
4. Conotoxin modulation of voltage-gated sodium channels.
Ekberg J; Craik DJ; Adams DJ
Int J Biochem Cell Biol; 2008; 40(11):2363-8. PubMed ID: 17951097
[TBL] [Abstract][Full Text] [Related]
5. Conotoxins That Could Provide Analgesia through Voltage Gated Sodium Channel Inhibition.
Munasinghe NR; Christie MJ
Toxins (Basel); 2015 Dec; 7(12):5386-407. PubMed ID: 26690478
[TBL] [Abstract][Full Text] [Related]
6. Isolation, characterization and total regioselective synthesis of the novel μO-conotoxin MfVIA from Conus magnificus that targets voltage-gated sodium channels.
Vetter I; Dekan Z; Knapp O; Adams DJ; Alewood PF; Lewis RJ
Biochem Pharmacol; 2012 Aug; 84(4):540-8. PubMed ID: 22609441
[TBL] [Abstract][Full Text] [Related]
7. Interactions of disulfide-deficient selenocysteine analogs of μ-conotoxin BuIIIB with the α-subunit of the voltage-gated sodium channel subtype 1.3.
Green BR; Zhang MM; Chhabra S; Robinson SD; Wilson MJ; Redding A; Olivera BM; Yoshikami D; Bulaj G; Norton RS
FEBS J; 2014 Jul; 281(13):2885-98. PubMed ID: 24814369
[TBL] [Abstract][Full Text] [Related]
8. Navβ subunits modulate the inhibition of Nav1.8 by the analgesic gating modifier μO-conotoxin MrVIB.
Wilson MJ; Zhang MM; Azam L; Olivera BM; Bulaj G; Yoshikami D
J Pharmacol Exp Ther; 2011 Aug; 338(2):687-93. PubMed ID: 21586605
[TBL] [Abstract][Full Text] [Related]
9. Selective Voltage-Gated Sodium Channel Peptide Toxins from Animal Venom: Pharmacological Probes and Analgesic Drug Development.
Wu Y; Ma H; Zhang F; Zhang C; Zou X; Cao Z
ACS Chem Neurosci; 2018 Feb; 9(2):187-197. PubMed ID: 29161016
[TBL] [Abstract][Full Text] [Related]
10. Computational Design of High-Affinity Blockers for Sodium Channel Na
Meng G; Kuyucak S
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200683
[TBL] [Abstract][Full Text] [Related]
11. µ-Conotoxins Targeting the Human Voltage-Gated Sodium Channel Subtype Na
McMahon KL; Tran HNT; Deuis JR; Craik DJ; Vetter I; Schroeder CI
Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136538
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Classes of
Jimenez EC
Protein Pept Lett; 2023; 30(11):913-929. PubMed ID: 38008946
[TBL] [Abstract][Full Text] [Related]
13. Scorpion Toxins Targeting Voltage-gated Sodium Channels Associated with Pain.
Xu Y; Sun J; Liu H; Sun J; Yu Y; Su Y; Cui Y; Zhao M; Zhang J
Curr Pharm Biotechnol; 2018; 19(11):848-855. PubMed ID: 30398114
[TBL] [Abstract][Full Text] [Related]
14. Α- and β-subunit composition of voltage-gated sodium channels investigated with μ-conotoxins and the recently discovered μO§-conotoxin GVIIJ.
Wilson MJ; Zhang MM; Gajewiak J; Azam L; Rivier JE; Olivera BM; Yoshikami D
J Neurophysiol; 2015 Apr; 113(7):2289-301. PubMed ID: 25632083
[TBL] [Abstract][Full Text] [Related]
15. The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by associating with domain-3.
Zorn S; Leipold E; Hansel A; Bulaj G; Olivera BM; Terlau H; Heinemann SH
FEBS Lett; 2006 Feb; 580(5):1360-4. PubMed ID: 16458302
[TBL] [Abstract][Full Text] [Related]
16. Mu-conotoxins as leads in the development of new analgesics.
Norton RS
Molecules; 2010 Apr; 15(4):2825-44. PubMed ID: 20428082
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional insights into the inhibition of human voltage-gated sodium channels by μ-conotoxin KIIIA disulfide isomers.
Tran HNT; McMahon KL; Deuis JR; Vetter I; Schroeder CI
J Biol Chem; 2022 Mar; 298(3):101728. PubMed ID: 35167877
[TBL] [Abstract][Full Text] [Related]
18. Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues.
Walewska A; Han TS; Zhang MM; Yoshikami D; Bulaj G; Rolka K
Eur J Med Chem; 2013 Jul; 65():144-50. PubMed ID: 23707919
[TBL] [Abstract][Full Text] [Related]
19. Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.
Khoo KK; Feng ZP; Smith BJ; Zhang MM; Yoshikami D; Olivera BM; Bulaj G; Norton RS
Biochemistry; 2009 Feb; 48(6):1210-9. PubMed ID: 19170536
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of Na(V)β subunits alters the kinetics of inhibition of voltage-gated sodium channels by pore-blocking μ-conotoxins.
Zhang MM; Wilson MJ; Azam L; Gajewiak J; Rivier JE; Bulaj G; Olivera BM; Yoshikami D
Br J Pharmacol; 2013 Apr; 168(7):1597-610. PubMed ID: 23146020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
